Kevin Rakin

Kevin is Co-founder of HighCape Partners and brings more than 25 years of experience as an executive in the life sciences industry. He most recently served as President of Shire Regenerative Medicine. Prior to joining Shire, Kevin was the Chairman and Chief Executive Officer of Advanced BioHealing from 2007 until its acquisition by Shire in 2011. Before that, he served as an Executive-in-Residence at Canaan Partners. Previously, he was Co-founder, President, and Chief Executive Officer of Genaissance Pharmaceuticals, Inc., a publicly held pharmacogenomics company, until its merger with Clinical Data, Inc. in 2005. He currently serves as a Board Member of Cheetah Medical, Inc. (Chairman), Histogenics Corp., Collagen Matrix, Inc., TELA Bio, Inc., and CURE, Connecticut’s bioscience cluster. Kevin received an MBA from Columbia University and his MS in Finance and BS in Business from the University of Cape Town, South Africa.